Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03870360 · ClinicalTrials.gov registry record · NA
Preventing Anxiety and Depression in Older Hispanics
A NA study of Depression and Anxiety, sponsored by University of Miami.
- Active
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT03870360: Active NA study of Depression and Anxiety, sponsored by University of Miami.
NCT03870360 is a NA study of Depression and Anxiety that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 240 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03870360, a NA study of Depression and Anxiety, is active but no longer recruiting, sponsored by University of Miami.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at the best ways to prevent anxiety and depression in older Latino adults who are at risk for developing anxiety and depression. Participants will be randomized to either a health promotion intervention or a healthy lifestyles education program.
Primary Outcome
As measured by the Beck Depression Inventory that has a range of scores from 0-63 with scores of 0-9 being minimal depression, 10-18 mild depression, 19-29 moderate depression, and 30-63 severe depression.
Conditions Studied
Interventions
- BEHAVIORAL HOLA Component 1
- BEHAVIORAL HOLA Component 2
- BEHAVIORAL HOLA Component 3
- BEHAVIORAL HOLA Component 4
- BEHAVIORAL Healthy lifestyles education program
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What the registry record for NCT03870360 still lists
NCT03870360 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which HOLA Component 1 is the first listed.
NCT03870360 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03870360 about?
NCT03870360 is a clinical study titled "Preventing Anxiety and Depression in Older Hispanics". The purpose of this study is to look at the best ways to prevent anxiety and depression in older Latino adults who are at risk for developing anxiety and depression. Participants will be randomized to either a health promotion intervention or a healthy lifestyles education program.
What is the current status of trial NCT03870360?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2022-11-01. Estimated completion is 2026-06-01.
What conditions does trial NCT03870360 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT03870360?
The interventions under investigation include: HOLA Component 1 (BEHAVIORAL), HOLA Component 2 (BEHAVIORAL), HOLA Component 3 (BEHAVIORAL), HOLA Component 4 (BEHAVIORAL), Healthy lifestyles education program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03870360?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03870360 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03870360's enrollment target sits among peer trials
240 177th of 679 higher than 494 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy